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ABSTRACT
Background and Objectives: Information about the role of the stromal cell-derived factor-
1α (SDF-1α)/chemokine receptor type 4 (CXCR4) axis in ischemic postconditioning (IPOC) 
is currently limited. We hypothesized that the SDF-1α/CXCR4 signaling pathway is directly 
involved in the cardioprotective effect of IPOC.
Methods: Isolated rat hearts were divided into four groups. The control group was subjected 
to 30-min of regional ischemia and 2-hour of reperfusion (n=12). The IPOC group was 
induced with 6 cycles of 10-second reperfusion and 10-second global ischemia (n=8) in each 
cycle. The CXCR4 antagonist, AMD3100, was applied before reperfusion in the IPOC group 
(AMD+IPOC group, n=11) and control group (AMD group, n=9). Hemodynamic changes 
with electrocardiography were monitored and infarct size was measured. The SDF-1α, lactate 
dehydrogenase (LDH) and creatine kinase (CK) concentrations in perfusate were measured. 
We also analyzed extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt phosphorylation 
state expression.
Results: IPOC significantly reduced infarct size, but AMD3100 attenuated the infarct 
reducing effect of IPOC. IPOC significantly decreased LDH and CK, but these effects were 
reversed by AMD3100. ERK1/2 and Akt phosphorylation increased with IPOC and these 
effects were blocked by AMD3100.
Conclusion: Based on the results of this study, SDF-1α/CXCR4 signaling may be involved in 
IPOC cardioprotection and this signaling pathway couples to the ERK1/2 and Akt pathways.
Keywords: Reperfusion injury; Ischemic postconditioning; Stromal cell-derived factor-1α; 
CXCR4 receptors
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INTRODUCTION
Ischemic postconditioning (IPOC) may offer beneficial cardioprotection against myocardial 
ischemia/reperfusion (I/R) injury through repetitive episodes of I/R at the beginning of 
reperfusion after a prolonged period of ischemia, by intrinsic prosurvival signaling cascade 
activation.1-3)
Over the past two decades, there has been increasing interest in IPOC because of its comparable 
cardioprotective effect to ischemic preconditioning, which is achieved by brief periods of I/R 
injury before a prolonged period of ischemia. This approach may provide greater therapeutic 
potential since it could be performed at the time of reperfusion therapy, for instance 
percutaneous coronary intervention for acute myocardial infarction, or at the time of cardiac 
surgery, for example in coronary artery bypass surgery and heart transplantation. Underlying 
mechanisms for IPOC have been proposed, including, endothelial nitric oxide, free radicals, 
survival kinases, opioids, and ATP-sensitive potassium channels.4-6)
In comparison, stromal cell-derived factor-1α (SDF-1α or CXCL12) is a chemotactic cytokine 
that promotes angiogenesis as well as recruiting stem and progenitors cells to the site of injured 
organs through cognate chemokine receptor type 4 (CXCR4).7)8) Furthermore, recent studies 
have indicated that activation of the SDF-1α/CXCR4 axis has a direct role in cell protection and 
survival, not only against hypoxia/reoxygenation damage in vitro but also myocardial I/R injury 
in vivo.9) In addition, the SDF-1α/CXCR4 axis is linked to a series of downstream signaling 
pathways through activation of prosurvival kinase against I/R injury.4)10)
However, even though the SDF-1α/CXCR4 axis has been studied extensively, information 
about its role in IPOC is limited. In this study, we hypothesized that the SDF-1α/CXCR4 
signaling pathway is directly involved in the cardioprotective effect of IPOC, and this study 
was designed to address this issue. We used a highly selective CXCR4 antagonist (AMD3100) 
in an IPOC-induced isolated rat heart model to remove any potential confounding effects 
derived from systemic effects on the infarcted heart.
METHODS
The experimental procedures and protocols used in this study were reviewed and approved by 
our Institutional Animal Care and Use Committee (PNU-2011-000292).
Chemicals
AMD3100, the highly selective CXCR4 antagonist, 1,1′-[1,4-phenylenebis-(methylene)]-bis-
(1,4,8,11-tetraazacyclotetradecane) octahydrochloride was purchased from Tocris Bioscience 
(Ellisville, MO, USA). 2,3,5-triphenyltetrazolium chloride (TTC) was obtained from Sigma-
Aldrich Chemical (St. Louis, MO, USA). Fluorescent polymer microspheres were purchased 
from Duke Scientific (Palo Alto, CA, USA). Antibodies against extracellular signal-regulated 
kinase 1/2 (ERK1/2) and Akt were purchased from Cell Signaling Technology Inc. (Beverly, 
MA, USA). Other chemicals were obtained from Sigma-Aldrich Chemical.
Langendorff-perfused heart isolation
Male Sprague-Dawley rats that weighed 280–330 g were obtained from KOATECH Co., 
Cheongju, Korea. They received 50 mg/kg of pentobarbital sodium (Entobar®, Yongin, Korea) 
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and 300 IU of heparin intraperitoneally. A median thoracotomy was performed after anesthesia 
and hearts were isolated and immediately connected to the Langendorff system via the aorta. 
Hearts were then perfused with modified Krebs-Henseleit buffer solution that contained (in 
mM) 118.5 NaCl, 4.7 KCl, 1.2 MgSO4, 1.8 CaCl2, 24.8 NaHCO3, 1.2 KH2PO4, and 10 glucose, as 
described previously.5) The proximal portion of the left coronary artery (LCA) was first localized 
between the left atrial appendage and the right ventricular outflow tract to induce regional 
ischemia. A 6–0 polypropylene suture was then passed around the major trunk or prominent 
branches of the LCA. The ends of the thread were passed through a small piece of PE50 tube to 
form a snare. All hearts were allowed to stabilize for at least 30 minutes. Ischemia was induced 
by pulling the snare then fixing it by clamping the tube with a small hemostat and confirmed by 
regional cyanosis, a substantial decrease in left ventricular developed pressure (LVDP), or a fall 
in coronary flow (CF). Reperfusion was initiated by releasing the snare. Hearts that experienced 
ventricular fibrillation (VF) after reperfusion typically spontaneously reverted to sinus rhythm. 
VF that lasted more than 45 seconds was treated with finger flick cardioversion until a perfusing 
rhythm was obtained. No pharmacological agents were used for defibrillation.
Experimental protocol
Hearts were randomly divided into 4 groups to investigate the involvement of the SDF-1α/
CXCR4 axis in the IPOC-induced infarct limitation effect: 1) CON group (n=12), untreated 
control hearts subjected to 30 minutes of regional ischemia and 120 minutes of reperfusion; 
2) IPOC group (n=8), 6 cycles of 10 seconds of reperfusion followed by 10 seconds of global 
ischemia immediately after the index ischemia; 3) AMD+IPOC group (n=11), AMD3100 
pretreatment in the IPOC group; and 4) AMD group (n=9), AMD3100 in control hearts 
(Figure 1).5) In the AMD+IPOC and AMD groups, 1 µM of AMD3100 was perfused, starting 
20 minutes before reperfusion and allowed up to 30 minutes of reperfusion. The AMD3100 
concentration was based on our previous report on isolated working rat hearts.11)
Cardiac function assessment
An air-bubble free, fluid-filled latex balloon was inserted into the left ventricle (LV) through 
the left atrial appendage in isolated hearts to assess cardiac function. Balloon volume was 
951https://e-kcj.org https://doi.org/10.4070/kcj.2016.0353
Cardioprotective Role of the SDF-1α/CXCR4 Axis in Ischemic Postconditioning
Stabilization Ischemia (30 minutes) Reperfusion (120 minutes)
CON (n=12)
AMD 3100
AMD (n=9)
Ischemia postconditioning (6 cycles)
IPOC (n=8)
AMD 3100
Ischemia postconditioning (6 cycles)
AMD+IPOC (n=11)
-30′ 0′ 30′2′ 120′
Figure 1. Experimental protocol. CON group was subjected to 30 minutes of regional ischemia followed by 120 
minutes of reperfusion. IPOC group was induced by 6 cycles of 10 seconds reperfusion and 10 seconds global 
ischemia immediately after reperfusion. CXCR4 antagonist AMD3100 was administered from 20 minutes before 
reperfusion to 30 minutes after reperfusion. 
CON = untreated control hearts (n=12); CXCR4 = chemokine receptor type 4; IPOC = ischemic postconditioning (n=8).
adjusted with the BIOPAC system (BIOPAC Systems Inc., Goleta, CA, USA) to provide and 
sustain a left ventricular end-diastolic pressure (LVEDP) of 5–10 mmHg. LVDP was calculated as 
the difference between the left ventricular systolic pressure (LVSP) and LVEDP. Rate-pressure 
product (RPP) was calculated as the LVDP × heart rate (HR). CF was measured by timing the 
perfusate that dripped from the right heart into a graduated cylinder. Cardiodynamic data 
including HR, LVSP, LVEDP, and the maximum first derivative of left ventricular pressure (+dP/
dtmax) was obtained and analyzed using analysis software, BSL v3.7.3 (BIOPAC Systems Inc.).
Area at risk (AR) and infarct size
After 2 hours of reperfusion, the AR and area of necrosis (AN) were demarcated by diluted 
fluorescent polymer microspheres and TTC stain, as described previously.11) The LV was 
removed from the remaining tissue. The AR and AN zones in the LV were quantified with 
Image Tool (UTHSCSA Image Tool version 3.0; University of Texas Health Science Center, 
San Antonio, TX, USA) and were converted into volumes by multiplying the areas by the slice 
thickness (2 mm). The volume of AN was expressed as a percentage of the AR volume. All 
measurements were blinded.
Myocardial necrosis
Myocardial necrosis in the CON, IPOC, and AMD+IPOC groups was evaluated by measuring 
the release of lactate dehydrogenase (LDH) and creatine kinase (CK) in the coronary effluent 
collected at 60 minutes after reperfusion. Assays for LDH and CK involved ultraviolet (UV)-
rate methods and were based on manufacturer's instructions (TBA-200 FR NEO; Denka 
Seiken Co., Tokyo, Japan). Units are expressed as IU/L and U/L, respectively.
Enzyme-linked immunosorbent assay (ELISA) test for SDF-1α
Concentrations of SDF-1α in perfusate were measured at 60 minutes after reperfusion using 
the rat SDF-1α ELISA kit, according to manufacturer's recommendations (Cusabio Biotech 
Co., Ltd., Hubei, China). Optical density (OD) was measured using a spectrophotometer at 
a wavelength of 450±2 nm and the concentration of SDF-1α in the samples was determined 
by comparing the OD of the samples to the standard curve. The SDF-1α was expressed in pg/
mL. The SDF-1α concentration in each sample was the average of 2 independent experiments, 
each from a different heart. Additionally, the concentration of SDF-1α in non-infarcted sham 
hearts (n=8) was measured for comparison with infarcted groups.
Confocal immunofluorescence microscopy
The heart tissues were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS), then 
permeabilized with 0.1% Triton X-100 in PBS for 10 minutes, and then blocked with 2% bovine 
serum albumin (BSA). The SDF-1 primary antibody was incubated at a 1:200 dilution overnight 
at 4°C. Next, the hearts were repeatedly washed with PBS and incubated with Alexa Fluor 488 
goat anti-rabbit immunoglobulin G (IgG) (H+L) for 2 hours at room temperature. The tissues 
were repeatedly washed in PBS and then stained with 100 ng/mL 4',6-diamidino-2-phenylindole 
(DAPI; Sigma-Aldrich Chemical) in PBS for 10 minutes. Stained heart tissues were analyzed 
using an upright spectral laser scanning confocal microscope (Model FV 1000; Olympus, Tokyo, 
Japan) equipped with a blue argon (for DAPI) and green argon (for Alexa Fluor 488) laser. Image 
processing, analysis, and the extent of colocalization were evaluated with FV10-ASW software.
Tissue lysate preparation and western blot analysis
Additional hearts were randomly assigned into the CON, IPOC, and AMD+IPOC groups 
(each n=6). Myocardial samples were taken 10 minutes after reperfusion from isolated rat 
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hearts and were homogenized in ice-cold lysis buffer. Equal amounts of protein (50 µg/
lane) were loaded and electrophoresed on sodium dodecyl sulfate (SDS)-polyacrylamide 
gel and transferred to a polyvinylidene difluoride membrane. Membranes were blocked 
with nonfat milk and then incubated at 4°C overnight with primary antibodies to facilitate 
Akt and ERK1/2 phosphorylation. Primary antibody binding was detected with a secondary 
anti-rabbit antibody and visualized with enhanced chemiluminescence. Data for total- and 
phospho-ERK1/2 represent the sum of the 42- and 44-kDa bands.
Statistical analysis
Data are expressed as mean±standard deviation (SD). Data analysis was performed with a 
statistical software package (SPSS for Windows, Release 12.0; SPSS Inc., Chicago, IL, USA). 
Data were analyzed using 1-way and 2-way analysis of variance (ANOVA) followed by post-hoc 
multiple comparison tests. A value of p<0.050 was considered significant.
RESULTS
CF and cardiodynamics
Table 1 summarizes the CF and hemodynamic parameters, including HR, LVDP, RPP, and +dP/
dtmax in all groups determined at baseline, and at 30 minutes and 120 minutes after reperfusion. 
There were no significant differences in baseline CF and cardiodynamic variables. There were 
no significant differences in CF and cardiodynamic variables after reperfusion.
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Table 1. CF and cardiodynamics in isolated hearts
Parameters Baseline Reperfusion (30 mintues) Reperfusion (120 mintues)
CF (mL/min/g)
CON 12.7±3.5 7.8±4.8 7.5±5.0
IPOC 11.2±2.8 8.5±2.7 5.9±2.7
AMD+IPOC 11.3±1.8 6.9±2.9 4.3±3.2
AMD 13.0±2.6 8.2±6.8 5.6±5.1
HR (beats/min)
CON 272.4±32.5 235.2±43.1 202.4±74.5
IPOC 257.6±16.7 228.7±29.7 176.0±54.4
AMD+IPOC 258.7±43.1 186.4±67.7 158.8±62.5
AMD 284.5±49.3 189.3±58.0 177.0±57.4
LVDP (mmHg)
CON 124.8±20.6 77.8±24.4 47.1±19.2
IPOC 122.6±14.3 88.2±22.9 53.1±25.7
AMD+IPOC 124.7±25.0 71.3±33.8 46.0±24.4
AMD 127.4±27.5 53.3±19.8 46.9±16.9
RPP (mmHg·beats/min·103)
CON 34.0±7.0 19.0±8.8 10.4±7.4
IPOC 31.7±5.1 20.4±6.5 10.4±6.1
AMD+IPOC 32.1±7.5 14.5±9.9 7.4±5.6
AMD 36.3±10.8 9.3±5.3 8.9±5.2
+dP/dtmax (mmHg/sec·103)
CON 2.6±1.0 1.5±0.5 0.9±0.3
IPOC 2.6±0.3 1.7±0.4 1.1±0.5
AMD+IPOC 2.4±0.7 1.3±0.6 0.8±0.3
AMD 2.5±0.4 1.0±0.3 0.7±0.4
Data expressed as mean±standard deviation.
AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); CF = 
coronary flow; CON = untreated control hearts (n=12); CXCR4 = chemokine receptor type 4; HR = heart rate; IPOC 
= ischemic postconditioning (n=8); LVDP = left ventricular developed pressure; RPP = rate-pressure product; +dP/
dtmax = maximum first derivative of left ventricular pressure.
Infarct size
There were no significant differences between groups with respect to body weight, heart 
weight, LV volume, AR volume, and AR/LV (Table 2). The AR ranged from 54.5% to 61.7% of 
the LV volume, which indicates that an equivalent degree of regional ischemia was induced 
among the groups. AN/AR was significantly reduced in the IPOC group (17.8±7.0%) compared 
with the control group (29.3±8.4%, p=0.022; Figure 2). This infarct reducing effect of IPOC 
was completely countered by AMD3100 pretreatment (28.5±8.9%, p=0.045 vs. IPOC group). 
AMD3100 did not have effect on infarct size (25.5±7.7%, p=1.000 vs. CON group).
Irreversible myocardial damage
Consistent with the change in AN/AR, the LDH concentration in the IPOC group (31.5±15.5 
IU/L) was decreased significantly compared to the CON group (101.9±60.3 IU/L, p=0.020). 
However, the level of LDH was completely reversed by pretreatment with AMD3100 
(116.4±94.5 IU/L, p=0.047 vs. IPOC group; Figure 3). Similarly, the CK level was significantly 
lower in the IPOC group than in the CON group (44.8±24.4 U/L vs. 122.7±80.0 U/L, 
respectively, p=0.048), and these changes of CK were completely reversed by AMD3100 
(152.7±116.4 U/L, p=0.042; Figure 3).
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Table 2. Morphometric data
Group BW (gm) HW (gm) LV volume (cm3) AR volume (cm3) AR/LV (%)
CON 300.4±15.9 1.56±0.15 0.706±0.110 0.423±0.093 59.6±6.9
IPOC 297.5±21.4 1.58±0.17 0.736±0.134 0.401±0.090 54.5±5.1
AMD+IPOC 293.3±16.9 1.53±0.16 0.769±0.084 0.470±0.065 61.5±8.4
AMD 291.9±11.9 1.51±0.12 0.742±0.098 0.458±0.062 61.7±3.3
Data expressed as mean±standard deviation. There were no significant differences among groups.
AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); AR = area at risk; BW = body weight; CON = untreated 
control hearts (n=12); CXCR4 = chemokine receptor type 4; HW = heart weight; IPOC = ischemic postconditioning (n=8); LV = left ventricle.
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Figure 2. (A) Representative sequential LV slices from each group showing the AN (pale area) with TTC staining. (B) Percent of infarct area over AR. 
All data are expressed as mean±standard deviation. There were significant differences between p=0.021 vs. CON group and p=0.045 vs. AMD+IPOC group. 
AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); AN = area of necrosis; AR = area at risk; CON = 
untreated control hearts (n=12); IPOC = ischemic postconditioning (n=8); TTC = 2,3,5-triphenyltetrazolium chloride.
SDF-1α concentrations and confocal immunofluorescence microscopy
The following SDF-1α concentrations were used: 6.06±0.23 pg/mL in the control heart group, 
7.76±1.66 pg/mL in the CON group, 7.25±1.61 pg/mL in the IPOC group, 7.49±2.17 pg/mL 
in the AMD+IPOC group, and 7.22±1.12 pg/mL in the AMD group. When we categorized 
these groups into a non-infarcted control heart group (n=8) versus infarcted groups (n=40), 
ischemia significantly induced myocardial SDF-1α production (6.06±0.23 pg/mL vs. 7.46±1.66 
pg/mL, respectively, p=0.023). However, IPOC group did not additionally increase SDF-1α 
concentrations, compared with the other 3 infarcted groups (p=0.880). Interestingly, SDF-
1α expression in the IPOC group was increased, compared with the control group or AMD 
group, based on confocal imaging. A reverse effect of AMD3100 was represented in the 
AMD+IPOC group by the decreased expression of SDF-1α/CXCR4 (Figure 4).
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Figure 3. Coronary effluent LDH and CK measured at 60 minutes after reperfusion. 
Data are expressed as mean±standard deviation. p<0.050 vs. CON group. 
AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); CK = creatine kinase; CON = untreated control 
hearts (n=12); IPOC = ischemic postconditioning (n=8); LDH = lactate dehydrogenase.
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Figure 4. Confocal image of representative immunofluorescent staining for SDF-1 (green), DAPI (blue, nuclear DNA), and merged image from isolated perfused rat hearts. 
AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); CON = untreated control hearts (n=12); DAPI = 
4',6-diamidino-2-phenylindole; IPOC = ischemic postconditioning (n=8); SDF-1 = stromal cell-derived factor-1.
Western immunoblots
ERK1/2 (Thr202/Tyr204) and protein kinase B or Akt (Ser473) phosphorylation was measured 
in perfused rat hearts. IPOC significantly increased ERK1/2 phosphorylation (226.1±71.8%, 
p=0.010 vs. CON group) after reperfusion (Figure 5). The increased ERK1/2 phosphorylation 
in IPOC was attenuated by the CXCR4 antagonist AMD3100 (83.8±28.0%, p=0.020 vs. IPOC 
group). IPOC also significantly increased Akt phosphorylation (296.4±93.1%, p=0.020) after 
reperfusion, compared to control hearts. The increased Akt phosphorylation in IPOC was 
completely blocked by AMD3100 (138.3±28.5%, p=0.009 vs. IPOC group).
DISCUSSION
In this study, we demonstrated that IPOC effectively reduced myocardial infarction and 
the levels of LDH and CK following I/R injury. This result is comparable with other studies 
performed in isolated rat hearts.2-12) Interestingly, the infarct limitation effect of IPOC was 
totally countered by AMD3100. In addition, the increasing effect in phosphorylation of 
ERK1/2 and Akt by IPOC was completely attenuated by AMD3100. Altogether, the results of 
this study strongly suggest, that the intracardiac protective effect of IPOC was modulated by 
the SDF-1α cognate receptor, CXCR4, in isolated rat hearts.
SDF-1α is the predominant isoform of SDF-1 and it is constitutively expressed in many 
tissues. CXCR4 is a member of the guanine nucleotide binding protein-coupled receptors 
(GPCRs) superfamily and a specific receptor for SDF-1α.13) SDF-1α plays an important 
role in organogenesis, cell proliferation, and in pathophysiological processes such as 
migration of bone marrow-derived stem cell and endothelial progenitor cells, which 
express CXCR4, into ischemic injury sites.8) It is well established that SDF-1α and CXCR4 
expression increases under hypoxic conditions, such as myocardial infarction/injury.7)14) 
Additionally, recent evidence has indicated that the SDF-1α/CXCR4 axis has a direct and rapid 
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Figure 5. (A) Representative western blotting for p-Akt and t-Akt intensity. (B) Representative western blotting for p-ERK1/2 and t-ERK1/2 intensity. Bar graph 
shows percentage change in ERK1/2 and Akt phosphorylation relative to CON group. 
Increased phosphorylation of Akt and ERK1/2 in IPOC-induced hearts was totally blocked by AMD3100. Data are expressed as mean±standard deviation. p<0.050 
vs. CON group. 
AMD = AMD3100 treatment in CON (n=9); AMD+IPOC = CXCR4 antagonist AMD3100 treatment in IPOC (n=11); CON = untreated control hearts (n=12); IPOC 
= ischemic postconditioning (n=8); p-Akt = phospho-Akt; p-ERK1/2 = phospho-extracellular signal-regulated kinase 1/2; t-Akt = total-Akt; t-ERK1/2 = total-
extracellular signal-regulated kinase 1/2.
cardioprotective effect from myocardial I/R injury. Segret et al.15) showed increased SDF-1α/
CXCR4 expression in isolated cardiomyocytes and in the rat myocardial infarction model, 
based on immunohistochemistry results, and suggested that increased SDF-1α levels may 
directly contribute to cardiac function recovery via an autocrine and/or paracrine mechanism. 
Moreover, Hu et al.9) found that SDF-1α expression increased early in cardiomyocytes cultured 
under hypoxic conditions as well as in in vivo ischemic preconditioning. They also reported 
that exogenous administration of SDF-1α protects the myocardium from I/R injury and that 
administration of AMD3100 before SDF-1α treatment blocked the cardioprotective effect 
of SDF-1α. Huang et al.10) showed that exogenously administered SDF-1α improved post-
ischemic myocardial function recovery and those effects were countered by administration 
of AMD3100 in acute myocardial I/R injury models with isolated mouse hearts. Our very 
recent data demonstrated that exogenously sustained SDF-1α targeting reperfusion also 
effectively reduced myocardial infarction in a dose-dependent manner in isolated rat hearts.11) 
Altogether, exogenous administration of SDF-1α to target both ischemia and reperfusion 
effectively protects after myocardial I/R injury.
We verified the difference in SDF-1α protein levels between the non-infarcted control group 
and the four experimental infarcted groups. The IPOC did not increase SDF-1α protein levels, 
compared with the CON group at 60 minutes after IPOC. However, in confocal imaging, SDF-
1α expression of the IPOC group increased, compared with the control group or AMD group 
and a reverse effect of AMD3100 was represented in the AMD+IPOC group by the decreased 
expression of SDF-1α/CXCR4 (Figure 4). In our study, IPOC significantly reduced infarct size 
as well as cardiac enzymes levels, and AMD3100 completely reversed the infarct-reducing 
effect of IPOC. There are several possibilities that could account for this result. First, there 
may be an undiscovered intermediate mechanism in the SDF-1α/CXCR4 axis for IPOC 
instead of the increasing release of SDF-1α, followed by CXCR4 activation. Second, sampling 
time for SDF-1α protein levels may have been too late, at 60 minutes after IPOC. Hu et al.'s 
study9) actually supports this hypothesis and showed that SDF-1α/CXCR4 pathway activation 
to modulate cardiomyocyte signaling in response to hypoxia/ischemia was very rapid and 
transient, occurring by 5 minutes and then disappearing by 30 minutes. Further research is 
warranted to address this possibility. Nonetheless, the present study reveals a crucial role for 
the SDF-1α/CXCR4 axis in mediating IPOC for cardioprotection against I/R injury.
In comparison, it is well-documented that IPOC mediates cardioprotection via activation of 
the reperfusion injury salvage kinase (RISK) pathways, such as ERK1/2 and phosphoinositide 
3-kinase (PI3K)/Akt.16) Zhu et al.17) found that the IPOC mediates cardioprotection via activation 
of the PI3K/Akt pathway in the remodeled rat myocardium and Yang et al.18) found that 
activation of the ERK1/2 component is required to mediate the protection induced by IPOC. 
Our present study yielded the same result, namely that IPOC significantly increased both 
ERK1/2 and Akt phosphorylation. Interestingly, AMD3100 completely inhibited IPOC-induced 
ERK1/2 and Akt phosphorylation. Based on this result, we hypothesize that CXCR4 is an 
upstream key component of ERK1/2 activation and Akt signaling by IPOC. It is also well known 
that myocardial STAT3 is involved in the cardioprotective effects of the SDF-1α/CXCR4 axis, but 
we did not examine the role of myocardial STAT3, therefore further research is needed.10)
Jujo et al.19) investigated the effect of CXCR blockade after myocardial infarction in a 
mouse model, and reported that continuous infusion of AMD3100 worsened functional 
myocardial recovery and neovascularization after myocardial infarction, which was explained 
by AMD3100 blockade of bone marrow-derived endothelial progenitor cells that were 
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incorporated in the heart. However, our study was performed in isolated working rat hearts, 
and the results indicated that the CXCR4 blocking effect of AMD3100 and the subsequent 
result in inhibiting the RISK pathway may need to be incorporated in the context of other 
studies to better understand this process. Further research is also warranted to investigate 
the mechanisms of these results.
GPCRs, which are introduced as cell surface proteins that convert extracellular stimuli into 
cellular signals, are solid established mediators in the IPOC pathway. Chen et al.20) and 
Methner et al.21) reported that the activation of GPCRs with ligands such as morphine or 
adenosine, effectively reduced infarct size at the time of reperfusion. Interestingly, there may 
be considerable cross-talk between GPCRs. For example, cardioprotection by the adenosine or 
opioid receptors may be countered by opioid or adenosine receptor antagonists.22) CXCR4 is a 
member of the GPCRs superfamily and it should be determined whether the role of CXCR4 in 
IPOC, as demonstrated in our study, is countered by other GPCRs antagonists in a future study.
In conclusion, our study was performed in an isolated heart model and demonstrates a new 
function for the SDF-1α/CXCR4 axis in IPOC. The SDF-1α/CXCR4 signaling may be directly 
involved in IPOC cardioprotection and this signaling pathway is coupled to downstream 
intracellular ERK1/2 and Akt signaling. We believe that these findings provide further insight 
into the underlying mechanisms and beneficial effects on IPOC against I/R injury.
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